Once-daily LABA/ICS combined inhalers versus inhaled longacting beta2-agonists for people with chronic obstructive pulmonary disease (COPD)

dc.contributorPontificia Universidad Javeriana. Facultad de Medicina. Departamento de Medicina Interna. Grupo de Investigación de Enfermedades Crónicas del Adulto
dc.creatorHidalgo, Patricia
dc.creatorCelis, Carlos A.
dc.creatorRojas Reyes, Maria Ximena
dc.creatorDennis, Rodolfo J.
dc.date.accessioned2020-05-26T19:41:51Z
dc.date.accessioned2022-09-22T20:46:17Z
dc.date.available2020-05-26T19:41:51Z
dc.date.available2022-09-22T20:46:17Z
dc.date.created2020-05-26T19:41:51Z
dc.identifier1361-6137
dc.identifierhttp://hdl.handle.net/10554/49449
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3466093
dc.rightsAtribución-NoComercial 4.0 Internacional
dc.rightshttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourceCochrane Database of Systematic Reviews; Núm. 2 (2016)
dc.titleOnce-daily LABA/ICS combined inhalers versus inhaled longacting beta2-agonists for people with chronic obstructive pulmonary disease (COPD)
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución